Department of Health changes advice on third generation pillsBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7190.1026a (Published 17 April 1999) Cite this as: BMJ 1999;318:1026
- Susan Mayor
The Department of Health announced last week that third generation oral contraceptives-pills containing gestodene and desogestrel-can now be offered as first line treatment, provided the slightly increased risk of deep vein thromobosis is explained to women.
The measure effectively reverses a recommendation made in 1995 by the Committee on Safety of Medicines (CSM), suggesting that these types of pill should only be used in women who are intolerant to other types. The CSM imposed the restriction after a study suggested a small increase in the risk of deep vein thrombosis. Doctors were …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial